Breakdown | |||||
TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
702.21M | 691.30M | 681.67M | 673.70M | 567.44M | 509.48M | Gross Profit |
381.06M | 326.94M | 434.00M | 438.78M | 369.64M | 325.16M | EBIT |
112.68M | 108.67M | 126.26M | 167.92M | 117.83M | 57.36M | EBITDA |
140.56M | 156.07M | 166.39M | 174.02M | 172.36M | 48.37M | Net Income Common Stockholders |
97.64M | 96.89M | 116.10M | 120.35M | 111.46M | 288.00K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
233.16M | 217.84M | 206.39M | 253.16M | 225.59M | 130.95M | Total Assets |
1.04B | 1.05B | 1.04B | 992.77M | 856.88M | 766.46M | Total Debt |
17.49M | 18.54M | 13.33M | 16.26M | 20.01M | 24.71M | Net Debt |
-72.67M | -103.75M | -66.87M | -124.95M | -84.08M | -94.47M | Total Liabilities |
148.11M | 148.56M | 146.88M | 177.60M | 153.55M | 219.59M | Stockholders Equity |
896.29M | 903.40M | 897.24M | 815.75M | 703.91M | 547.44M |
Cash Flow | Free Cash Flow | ||||
100.63M | 49.30M | 6.27M | 82.58M | 111.81M | 46.06M | Operating Cash Flow |
148.78M | 124.08M | 90.87M | 122.24M | 135.53M | 105.46M | Investing Cash Flow |
-91.29M | -31.50M | -76.90M | -28.01M | -134.43M | -12.28M | Financing Cash Flow |
-48.85M | -52.70M | -60.74M | -55.30M | -17.84M | -37.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £105.39M | 19.77 | 8.61% | 0.89% | -11.80% | -32.11% | |
76 Outperform | £3.31B | 14.34 | 17.33% | 3.39% | -11.09% | 65.87% | |
74 Outperform | £1.98B | 20.30 | 11.07% | 0.62% | 4.71% | 0.43% | |
71 Outperform | £150.59M | 29.08 | 4.79% | 2.91% | 1.74% | 359.50% | |
71 Outperform | £644.79M | 26.31 | 8.07% | 1.16% | -5.56% | -27.87% | |
70 Neutral | £525.16M | 50.40 | 12.29% | 0.95% | -1.84% | 9.56% | |
62 Neutral | $11.96B | 10.09 | -7.50% | 3.10% | 7.33% | -8.11% |
Renishaw hosted a Capital Markets Day to outline strategic progress and financial goals, including new product releases and changes to segmental reporting. The company aims to drive revenue growth through innovation, improve margins, and enhance shareholder returns with a new cost reduction program targeting £20 million in savings. The event highlighted significant investments in manufacturing capacity and introduced new business segments to better align with market demands.
The most recent analyst rating on (GB:RSW) stock is a Buy with a £4180.00 price target. To see the full list of analyst forecasts on Renishaw stock, see the GB:RSW Stock Forecast page.
Renishaw plc reported steady progress in its third quarter, with revenue reaching £180.7 million, marking a 5% increase year-on-year. The company experienced growth in machine tool probes and position encoders, while also announcing the closure of its loss-making drug delivery segment in the Neurological business to enhance profitability. Despite challenges such as tariffs and increased labor costs, Renishaw maintains a strong balance sheet and continues to focus on productivity and strategic investments to support future growth.
Renishaw plc announced a transaction involving its Chief Executive, William Ernest Lee, who acquired 1,788 ordinary shares at a price of £22.37 each on the London Stock Exchange. This acquisition reflects a significant investment by the company’s leadership, potentially indicating confidence in Renishaw’s future performance and market position.